Log in to search using one of your social media accounts:

This page shows you the latest news items in this category. This is page number 18.

Rheumatoid Arthritis: New Effective and Cheaper Treatment
Rheumatoid arthritis (RA) is a chronic auto-immune disease that causes pain and stiffness in the joints, fatigue, bone damage and, eventually, loss of mobility. RA afflicts around 1% of people in the western world; in Belgium, 80,000 to 100,000 people currently live with the disease. (Source: Disabled World)
Source: Disabled World - November 11, 2014 Category: Disability Tags: Rheumatoid Arthritis Source Type: news

New effective, safe and cheap treatment strategy for rheumatoid arthritis
A new drug combination for rheumatoid arthritis treats the disease just as well as other intensive treatment strategies but with less medication and fewer side effects at a significantly lower cost. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 10, 2014 Category: Science Source Type: news

New effective, safe and cheap treatment strategy for rheumatoid arthritis
(KU Leuven) A new drug combination for rheumatoid arthritis treats the disease just as well as other intensive treatment strategies but with less medication and fewer side effects at a significantly lower cost. Doctoral researcher Diederik De Cock describes the strategy in a new study published in Annals of Rheumatic Diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 10, 2014 Category: Global & Universal Source Type: news

Blood Test Could Prevent Medication Trial and Error for Rheumatoid Arthritis Patients
Boston — A molecule in the blood shows promise as a marker to predict whether individual rheumatoid arthritis patients are likely to benefit from biologic medications or other drugs should be tried, a Mayo Clinic-led study shows. The protein, analyzed in blood tests, may help avoid trial and error with medications, sparing patients treatment delays [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 10, 2014 Category: Databases & Libraries Source Type: news

Psoriasis or rheumatoid arthritis linked to heart risk
(Reuters Health) - Several conditions that stem from a malfunctioning immune system – psoriasis, psoriatic arthritis and rheumatoid arthritis – may create a higher than average risk for heart-related problems and death, a new study finds. (Source: Reuters: Health)
Source: Reuters: Health - November 6, 2014 Category: Consumer Health News Tags: healthNews Source Type: news

Drug-Free Remission a Reality in RA?
(MedPage Today) -- Study looks at possibility of absolute drug-free remission after removing all rheumatoid arthritis therapies. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - November 6, 2014 Category: Geriatrics Source Type: news

Lower Doses of Rheumatoid Arthritis Drugs May Work for Some
Title: Lower Doses of Rheumatoid Arthritis Drugs May Work for SomeCategory: Health NewsCreated: 11/5/2014 12:00:00 AMLast Editorial Review: 11/6/2014 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - November 6, 2014 Category: Rheumatology Source Type: news

Lower Doses of Rheumatoid Arthritis Drugs May Work for Some
Study found many patients with early stage disease stayed in remission with less medication (Source: WebMD Health)
Source: WebMD Health - November 5, 2014 Category: Consumer Health News Source Type: news

Lower Doses of Rheumatoid Arthritis Drugs May Work for Some
Study found many patients with early stage disease stayed in remission with less medication Source: HealthDay Related MedlinePlus Pages: Medicines, Rheumatoid Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 5, 2014 Category: Consumer Health News Source Type: news

Rheumatoid Arthritis: TNF Inhibitors Linked to Less Fatigue Rheumatoid Arthritis: TNF Inhibitors Linked to Less Fatigue
Patients with rheumatoid arthritis report substantial improvement of fatigue after beginning anti-tumor necrosis factor alpha therapy. Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 5, 2014 Category: Rheumatology Tags: Rheumatology News Source Type: news

Biosimilar Drugs Could Save Billions in Health Care
Introducing competing "biosimilar" versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut spending on biologics in the United States by $44 billion over the next decade, according to new analysis from the RAND Corporation. (Source: Disabled World)
Source: Disabled World - November 3, 2014 Category: Disability Tags: Pharmaceutical Source Type: news

Biosimilar drugs could create billions in health care savings, study finds
(RAND Corporation) The US Food and Drug Administration is expected soon to approve rules for introduction of 'biosimilars,' generic versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis. A new analysis finds that biosimilars could cut spending on biologics in the United States by $44 billion over the next decade, creating savings for patients, health care payers and taxpayers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 3, 2014 Category: Global & Universal Source Type: news

Biosimilar Medications Could Create Billions in Health Care Savings
Introducing competing “biosimilar” versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut spending on biologics in the United States by $44 billion over the next decade. (Source: RAND)
Source: RAND - November 3, 2014 Category: Health Management Authors: RAND Corporation Source Type: news

In autoimmune diseases affecting millions, researchers pinpoint genetic risks, cellular culprits
Scores of autoimmune diseases afflicting one in 12 Americans -- ranging from type 1 diabetes, to multiple sclerosis (MS), to rheumatoid arthritis, to asthma -- mysteriously cause the immune system to harm tissues within our own bodies. Now, a new study pinpoints the complex genetic origins for many of these diseases, a discovery that may lead to better diagnosis and ultimately to improved treatments. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 29, 2014 Category: Science Source Type: news

The Ghost of Pregnancies Past
For centuries, theologians have grappled with that line in Exodus 20:5, which states: “For I, the Lord your God, am a jealous God, visiting the iniquity of the fathers on the children to the third and fourth generations of those who hate Me.” From a genetic viewpoint, the iniquity of the fathers might occasionally miss its target, only to hit that innocent bystander, Mom.read more (Source: Psychology Today Sex Center)
Source: Psychology Today Sex Center - October 29, 2014 Category: Sexual Medicine Authors: Mark Borigini, M.D. Tags: Child Development Health Self-Help Sex chronic illness chronic pain chronic pain psychology today genes and pregnancy overcoming pain overcoming pain psychology today rheumatoid arthritis risk of rheumatoid arthritis Source Type: news

Ablynx reports positive results from Phase I bioavailability trial of SC ALX-0061
Belgium-based biopharmaceutical firm Ablynx has reported positive results from the Phase I bioavailability trial of the subcutaneous (SC) formulation of its anti-IL-6R Nanobody, ALX-0061, to treat inflammatory diseases such as rheumatoid arthritis (R… (Source: Drug Development Technology)
Source: Drug Development Technology - October 27, 2014 Category: Pharmaceuticals Source Type: news

Child's Genes Affect Mom's Risk for Rheumatoid ArthritisChild's Genes Affect Mom's Risk for Rheumatoid Arthritis
The fetal cells that circulate in a mother's body can increase her risk for rheumatoid arthritis. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 24, 2014 Category: Consumer Health News Tags: Pathology & Lab Medicine News Source Type: news

Diet and Rheumatoid Arthritis DevelopmentDiet and Rheumatoid Arthritis Development
What is the relationship between diet and the risk for developing rheumatoid arthritis? International Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 24, 2014 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Osteoporosis screening guidelines miss many younger post-menopausal women
To reduce the risk of bone fractures and the complications arising from them, the United States Preventive Services Task force (USPSTF) recommends that all women age 65 and older be tested and treated for low bone mineral density. The task force also recommends that postmenopausal women aged 50 to 64, get bone mineral density screenings if their 10-year probability of suffering a hip, vertebral, humerus or wrist fracture is 9.3 percent or greater, based on the Fracture Risk Assessment Tool. A new UCLA-led study published in The Journal of Clinical Endocrinology & Metabolism, however, finds that the USPSTF strategy pre...
Source: UCLA Newsroom: Health Sciences - October 22, 2014 Category: Universities & Medical Training Source Type: news

Father of woman's children may determine her risk of rheumatoid arthritis: study
Women may develop rheumatoid arthritis if they have babies with men carrying high risk genes, it has been suggested (Source: Telegraph Health)
Source: Telegraph Health - October 19, 2014 Category: Consumer Health News Source Type: news

Subcutaneous Tocilizumab: A Promising Alternative in Treating Rheumatoid Arthritis
No abstract available (Source: Lippincotts Bone and Joint Newsletter)
Source: Lippincotts Bone and Joint Newsletter - October 19, 2014 Category: Orthopaedics Tags: CME Article Source Type: news

Children's genes affect their mothers' risk of rheumatoid arthritis
(American Society of Human Genetics) A child's genetic makeup may contribute to his or her mother's risk of rheumatoid arthritis, possibly explaining why women are at higher risk of developing the disease than men. This research will be presented Tuesday, Oct. 21, at the American Society of Human Genetics 2014 Annual Meeting in San Diego. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - October 19, 2014 Category: Global & Universal Source Type: news

Roche delivers solid sales growth for the first nine months of 2014
Group sales up 5% at CER, stable in Swiss francs; 4% higher sales in Pharmaceuticals Division, with strong growth of oncology portfolio, as well as Actemra for rheumatoid arthritis and Xolair for asthma and chronic hives; 6% higher sales in Diagnostics Division, driven by strong Professional Diagnostics’ performance (Source: Roche Media News)
Source: Roche Media News - October 16, 2014 Category: Pharmaceuticals Source Type: news

Roche delivers solid sales growth for the first nine months of 2014
Group sales up 5% at CER, stable in Swiss francs; 4% higher sales in Pharmaceuticals Division, with strong growth of oncology portfolio, as well as Actemra for rheumatoid arthritis and Xolair for asthma and chronic hives; 6% higher sales in Diagnostics Division, driven by strong Professional Diagnostics’ performance (Source: Roche Investor Update)
Source: Roche Investor Update - October 16, 2014 Category: Pharmaceuticals Source Type: news

Hand exercises for rheumatoid arthritis
NIHR-funded research published in The Lancet today has found that tailored hand exercises improve the hand function of rheumatoid arthritis patients.Rheumatoid arthritis is a long-term condition that affects 400,000 people in the UK. It causes pain and stiffness in the joints and can greatly affect quality of life. Most people are treated with drugs that... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - October 10, 2014 Category: American Health Source Type: news

RheumShorts: Bone, Infections, and Cardiovascular Risk (CME/CE)
(MedPage Today) -- Seropositive rheumatoid arthritis can ruin trabecular bone. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - October 9, 2014 Category: Geriatrics Source Type: news

Small molecule 'jams the switch' to prevent inflammatory cell death
A small molecule that blocks a form of cell death that triggers inflammation has been discovered by scientists, opening the door for potential new treatments for inflammatory disease such as rheumatoid arthritis, Crohn's disease and psoriasis. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 7, 2014 Category: Science Source Type: news

Rheumatoid Arthritis: An Antigenic ChameleonRheumatoid Arthritis: An Antigenic Chameleon
How does smoking contribute to the risk for RA? Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 6, 2014 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Improve a weak immune system with probiotics
(NaturalNews) How do you know if you have a weak immune system? Simply put, frequent colds and flu, slow healing wounds or autoimmune conditions like, rheumatoid arthritis indicate compromised immune function. Thankfully, there is a natural way to strengthen immunity by consuming... (Source: NaturalNews.com)
Source: NaturalNews.com - October 3, 2014 Category: Consumer Health News Source Type: news

Eighty percent of bowel cancers halted with existing medicines
More than 80 percent of bowel cancers could be treated with existing drugs, an international team of scientists say at the conclusion of their study. The study found that medicines called 'JAK inhibitors' halted tumor growth in bowel cancers with a genetic mutation that is present in more than 80 per cent of bowel cancers. Multiple JAK inhibitors are currently used, or are in clinical trials, for diseases including rheumatoid arthritis, psoriasis, blood cancers and myeloproliferative disorders. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 1, 2014 Category: Science Source Type: news

Eighty percent of bowel cancers halted with existing medicines
(Walter and Eliza Hall Institute) An international team of scientists has shown that more than 80 percent of bowel cancers could be treated with existing drugs.The study found that medicines called 'JAK inhibitors' halted tumor growth in bowel cancers with a genetic mutation that is present in more than 80 per cent of bowel cancers. Multiple JAK inhibitors are currently used, or are in clinical trials, for diseases including rheumatoid arthritis, psoriasis, blood cancers and myeloproliferative disorders. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 1, 2014 Category: Cancer & Oncology Source Type: news

The Dance Between The Immune System and Stem Cells
We named it the  immunoLinkTM We have been testing a growing number of Clients with our Quantibody Arrays. Many of of these clients have Autoimmune Disorder Diseases. These range from Rheumatoid Arthritis to Multiple Sclerosis.These arrays are designed to precisely measure factors or markers (proteins) that are dysregulated by these diseases. We measure the levels of these biomarkers in our Clients' Blood serum. The arrays have also been used to measure the levels of markers in plasma and cell culture supernatants.Based on results, we are finding links between immune system and stem cell health. We call this the ...
Source: Neuromics - September 30, 2014 Category: Neuroscience Tags: autoimmune disease G-CSF GM-CSF Human Mesenchymal Stem Cells immune response immunoLink Neural Progenitor Cells Neural Stem Cell Markers Source Type: news

TNF Inhibitors and Breast Cancer RecurrenceTNF Inhibitors and Breast Cancer Recurrence
Dr Jonathan Kay discusses a recent article looking at breast cancer recurrence risk in patients treated with anti-TNF agents for rheumatoid arthritis. Medscape Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 30, 2014 Category: Consumer Health News Tags: Rheumatology Commentary Source Type: news

NIH announces network to accelerate medicines for rheumatoid arthritis and lupus
Partnership includes support from industry and non-profits. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 24, 2014 Category: American Health Source Type: news

NIH announces network to accelerate medicines for rheumatoid arthritis and lupus
(NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases) The National Institutes of Health has awarded grants to 11 research groups across the United States to establish the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus Network. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 24, 2014 Category: Global & Universal Source Type: news

Efficacy and Safety of Golimumab as Add-on Therapy to DMARDsEfficacy and Safety of Golimumab as Add-on Therapy to DMARDs
How safe and effective is subcutaneous golimumab as an add-on therapy in patients with active rheumatoid arthritis? Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 22, 2014 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

The incidence and risk factors for falls in adults with rheumatoid arthritis: A systematic review - Brenton-Rule A, Dalbeth N, Bassett S, Menz HB, Rome K.
OBJECTIVE: To conduct a systematic review of the incidence and risk factors for falls in people with rheumatoid arthritis (RA). METHODS: A search was conducted of the electronic databases AMED, CINAHL, MEDLINE, Scopus and The Cochrane Library. Stud... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - September 20, 2014 Category: Global & Universal Tags: Age: Elder Adults Source Type: news

Adding Chinese Herb to Methotrexate May Help Ease Active RAAdding Chinese Herb to Methotrexate May Help Ease Active RA
Patients with active rheumatoid arthritis (RA) may benefit from treatment with Tripterygium wilfordii Hook F (TwHF) and methotrexate (MTX), new research from China suggests. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 18, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Tampered Vials of Roche Injectable Cancer Drug Found in Germany
A German drug distributor has discovered three vials of Roche's cancer and rheumatoid-arthritis drug MabThera with evidence of tampering. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 16, 2014 Category: Pharmaceuticals Source Type: news

Salty Foods May Double Smokers' Risk of Rheumatoid Arthritis
Title: Salty Foods May Double Smokers' Risk of Rheumatoid ArthritisCategory: Health NewsCreated: 9/12/2014 12:36:00 PMLast Editorial Review: 9/15/2014 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - September 15, 2014 Category: Rheumatology Source Type: news

Salty Foods May Double Smokers' Risk of Rheumatoid Arthritis
About half of raised risk from tobacco tied to interaction with too much sodium, study finds (Source: WebMD Health)
Source: WebMD Health - September 12, 2014 Category: Consumer Health News Source Type: news

Salty Foods May Double Smokers' Risk of Rheumatoid Arthritis
About half of raised risk from tobacco tied to interaction with too much sodium, study finds Source: HealthDay Related MedlinePlus Pages: Dietary Sodium, Rheumatoid Arthritis, Smoking (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 12, 2014 Category: Consumer Health News Source Type: news

No innocent bystander: Cartilage contributes to arthritis
Cartilage plays an active role in the destruction and remodeling of joints seen in rheumatoid arthritis, rather than being an 'innocent bystander' as previously thought, researchers report. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 12, 2014 Category: Science Source Type: news

Director's Comments: NIH MedlinePlus Magazine Summer 2014
Listen to the NLM Director's Comments on "NIH MedlinePlus Magazine Summer 2014". The transcript is also available. The new edition of NIH MedlinePlus Magazine Summer 2014 covers rheumatoid arthritis, eye health, as well as information about breast cancer... (Source: What's New on MedlinePlus)
Source: What's New on MedlinePlus - September 11, 2014 Category: Consumer Health News Source Type: news

No innocent bystander: Cartilage contributes to arthritis
(Walter and Eliza Hall Institute) Melbourne researchers have discovered that cartilage plays an active role in the destruction and remodeling of joints seen in rheumatoid arthritis, rather than being an 'innocent bystander' as previously thought. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 11, 2014 Category: Biology Source Type: news

Shingles Risks Similar for the RA Biologics
(MedPage Today) -- The risk of developing herpes zoster was similar among older patients with rheumatoid arthritis (RA) treated with the various different biologic agents, a retrospective study found. (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - September 11, 2014 Category: Rheumatology Source Type: news

Blocking single receptor could halt rheumatoid arthritis
Researchers have shown for the first time how the activation of a receptor provokes the inflammation and bone degradation of rheumatoid arthritis -- and that activation of this one receptor, found on cells in the fluid of arthritic joints, is all that is required. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 10, 2014 Category: Science Source Type: news

Smokers who consume too much sodium at greater risk of developing rheumatoid arthritis
(Oxford University Press) A new study published online in the journal Rheumatology today indicates that the interaction between high sodium intake and smoking is associated with a more than doubled risk of developing rheumatoid arthritis. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 10, 2014 Category: Global & Universal Source Type: news

Jim Sullivan on Improving the Lives of Patients
At AbbVie, research and innovation are the cornerstones of our business as a global biopharmaceutical company. We focus on developing medicines that deliver strong clinical performance, provide more patient benefit and deliver economic value, particularly where there is significant need around the world in certain disease areas.  Arthritis is an example of a disease where we have the opportunity to continue to make headway to improve the lives of patients. According to the U.S. Centers for Disease Control and Prevention (CDC) prevalence of musculoskeletal diseases could increase from 52 million people in the U.S. to 67 mi...
Source: PHRMA - September 9, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Roche's rheumatoid arthritis drug wins EU approval for extended use
ZURICH (Reuters) - Swiss drugmaker Roche Holding AG said on Monday the European Union has approved the use of its drug RoActemra in patients with early-stage rheumatoid arthritis. (Source: Reuters: Health)
Source: Reuters: Health - September 8, 2014 Category: Consumer Health News Tags: healthNews Source Type: news